{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:05:38Z","timestamp":1788559538552,"version":"build-2803163510"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pharmaceutical grade sugars manufactured under Current Good Manufacturing Practice\n(cGMP) and complied with International Pharmaceutical Excipients Council (IPEC) quality standards,\nalso contain a significant amount of nano-particulate impurities (NPIs). This review will focus\non the origin of NPIs, the mechanism of their interference with Dynamic light scattering (DLS)\nand endotoxin tests, filtration technology to effectively reduce the NPIs, methodologies for analytical\nquantification of NPIs, guidance for setting the limits of threshold concentration and the\noverall impact of NPIs on the therapeutic activity, performance, stability of biopharmaceuticals\nand protein-based formulations. NPIs with an average particle size of 100 to 200 nm are present in\nsugars and are a combination of various chemicals such as dextrans (with the presence of\n&amp;#946;-glucans), ash, inorganic metal salts, aromatic colorants, etc. These NPIs primarily originate\nfrom raw materials and cannot be removed during the sugar refinement process. While it is commonly\nbelieved that filtering the final formulation with a 0.22 \u03bc sterilizing grade filter removes all\nmicrobes and particles, it is important to note that NPIs cannot be filtered using this standard sterile\nfiltration technology. Exceeding the threshold limit of NPIs can have detrimental effects on formulations\ncontaining proteins, monoclonal Antibodies (mAbs), nucleic acids, and other biopharmaceuticals.\nNPIs and &amp;#946;-glucans have a critical impact on the functionality and therapeutic activity\nof biomolecules and if present below the threshold limit of reaction, stability and shelf-life of biologics\nformulation will be greatly improved and the risk of immunogenic reactions must be significantly\ndecreased.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115672018290111240119115306","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T04:18:02Z","timestamp":1706761082000},"page":"659-665","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Influence of Nano-Particulate Impurities and \u03b2-glucans on the Stability of Protein-Based Formulations"],"prefix":"10.2174","volume":"22","author":[{"given":"Soumya Ranjan","family":"Satapathy","sequence":"first","affiliation":[{"name":"Department of Formulation and Development, DFE Pharma India Private Limited, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra Narayan","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha \u2018O' Anusandhan (Deemed to be University), Bhubaneswar,\nOdisha, 751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Nayak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha \u2018O' Anusandhan (Deemed to be University), Bhubaneswar,\nOdisha, 751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","volume":"11","author":"Zhu Q.","year":"2021","unstructured":"Zhu Q.; Chen Z.; Paul P.K.; Lu Y.; Wu W.; Qi J.; Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B  2021,11(8),2416-2448","journal-title":"Acta Pharm Sin B"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2144\/btn-2020-0155","volume":"70","author":"Chiba C.H.","year":"2021","unstructured":"Chiba C.H.; Knirsch M.C.; Azzoni A.R.; Moreira A.R.; Stephano M.A.; Cell-free protein synthesis: Advances on production process for biopharmaceuticals and immunobiological products. Biotechniques  2021,70(2),126-133","journal-title":"Biotechniques"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.addr.2021.02.016","volume":"172","author":"Chen Y.","year":"2021","unstructured":"Chen Y.; Mutukuri T.T.; Wilson N.E.; Zhou Q.T.; Pharmaceutical protein solids: Drying technology, solid-state characterization and stability. Adv Drug Deliv Rev  2021,172,211-233","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"120169","DOI":"10.1016\/j.ijpharm.2020.120169","volume":"594","author":"Mutukuri T.T.","year":"2021","unstructured":"Mutukuri T.T.; Wilson N.E.; Taylor L.S.; Topp E.M.; Zhou Q.T.; Effects of drying method and excipient on the structure and physical stability of protein solids: Freeze drying vs. spray freeze drying. Int J Pharm  2021,594,120169","journal-title":"Int J Pharm"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"118505","DOI":"10.1016\/j.ijpharm.2019.118505","volume":"568","author":"Wang W.","year":"2019","unstructured":"Wang W.; Ohtake S.; Science and art of protein formulation development. Int J Pharm  2019,568,118505","journal-title":"Int J Pharm"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s11095-015-1634-1","volume":"32","author":"Weinbuch D.","year":"2015","unstructured":"Weinbuch D.; Cheung J.K.; Ketelaars J.; Filipe V.; Hawe A.; den Engelsman J.; Jiskoot W.; Nanoparticulate impurities in pharmaceutical-grade sugars and their interference with light scattering-based analysis of protein formulations. Pharm Res  2015,32(7),2419-2427","journal-title":"Pharm Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"970499","DOI":"10.3389\/fimmu.2022.970499","volume":"13","author":"Thacker S.G.","year":"2022","unstructured":"Thacker S.G.; Her C.; Kelley-Baker L.; Ireland D.D.C.; Manangeeswaran M.; Pang E.S.; Verthelyi D.; Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients. Front Immunol  2022,13,970499","journal-title":"Front Immunol"},{"key":"ref=8","author":"Paul J. Sheskey","year":"2017","unstructured":"Paul J. Sheskey; Walter G Cook; Colin G Cable;  Association AP Handbook of pharmaceutical excipients  2017","journal-title":"Association AP Handbook of pharmaceutical excipients"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.colsurfb.2014.02.028","volume":"121","author":"Levacheva I.","year":"2014","unstructured":"Levacheva I.; Samsonova O.; Tazina E.; Beck-Broichsitter M.; Levachev S.; Strehlow B.; Baryshnikova M.; Oborotova N.; Baryshnikov A.; Bakowsky U.; Optimized thermosensitive liposomes for selective doxorubicin delivery: Formulation development, quality analysis and bioactivity proof. Colloids Surf B Biointerfaces  2014,121,248-256","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/08982104.2014.992023","volume":"25","author":"Kannan V.","year":"2015","unstructured":"Kannan V.; Balabathula P.; Thoma L.A.; Wood G.C.; Effect of sucrose as a lyoprotectant on the integrity of paclitaxel-loaded liposomes during lyophilization. J Liposome Res  2015,25(4),270-278","journal-title":"J Liposome Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/jps.23960","volume":"103","author":"Zelenkov\u00e1 T.","year":"2014","unstructured":"Zelenkov\u00e1 T.; Fissore D.; Marchisio D.L.; Barresi A.A.; Size control in production and freeze-drying of poly-\u03b5-caprolactone nanoparticles. J Pharm Sci  2014,103(6),1839-1850","journal-title":"J Pharm Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1166\/jnn.2012.6169","volume":"12","author":"Noh H.J.","year":"2012","unstructured":"Noh H.J.; Im A.R.; Kim H.S.; Sohng J.K.; Kim C.K.; Kim Y.S.; Cho S.; Park Y.; Antibacterial activity and increased freeze-drying stability of sialyllactose-reduced silver nanoparticles using sucrose and trehalose. J Nanosci Nanotechnol  2012,12(5),3884-3895","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/(SICI)1097-0290(19990420)63:2<166::AID-BIT5>3.0.CO;2-H","volume":"63","author":"Heller M.C.","year":"1999","unstructured":"Heller M.C.; Carpenter J.F.; Randolph T.W.; Protein formulation and lyophilization cycle design: Prevention of damage due to freeze-concentration induced phase separation. Biotechnol Bioeng  1999,63(2),166-174","journal-title":"Biotechnol Bioeng"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1128\/aem.61.10.3592-3597.1995","volume":"61","author":"Leslie S.B.","year":"1995","unstructured":"Leslie S.B.; Israeli E.; Lighthart B.; Crowe J.H.; Crowe L.M.; Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl Environ Microbiol  1995,61(10),3592-3597","journal-title":"Appl Environ Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.xphs.2019.10.055","volume":"109","author":"Starciuc T.","year":"2020","unstructured":"Starciuc T.; Malfait B.; Danede F.; Paccou L.; Guinet Y.; Correia N.T.; Hedoux A.; Trehalose or sucrose: Which of the two should be used for stabilizing proteins in the solid state? A dilemma investigated by in situ micro-raman and dielectric relaxation spectroscopies during and after freeze-drying. J Pharm Sci  2020,109(1),496-504","journal-title":"J Pharm Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1016\/S0021-9258(19)68947-7","volume":"256","author":"Lee J.C.","year":"1981","unstructured":"Lee J.C.; Timasheff S.N.; The stabilization of proteins by sucrose. J Biol Chem  1981,256(14),7193-7201","journal-title":"J Biol Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/02648725.2007.10648095","volume":"24","author":"Nobbmann U.","year":"2007","unstructured":"Nobbmann U.; Connah M.; Fish B.; Varley P.; Gee C.; Mulot S.; Chen J.; Zhou L.; Lu Y.; Sheng F.; Yi J.; Harding S.E.; Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies. Biotechnol Genet Eng Rev  2007,24(1),117-128","journal-title":"Biotechnol Genet Eng Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11051-007-9317-4","volume":"10","author":"Kaszuba M.","year":"2008","unstructured":"Kaszuba M.; McKnight D.; Connah M.T.; McNeil-Watson F.K.; Nobbmann U.; Measuring sub nanometre sizes using dynamic light scattering. J Nanopart Res  2008,10(5),823-829","journal-title":"J Nanopart Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1007\/s11095-017-2274-4","volume":"34","author":"Weinbuch D.","year":"2017","unstructured":"Weinbuch D.; Ruigrok M.; Jiskoot W.; Hawe A.; Nanoparticulate impurities isolated from pharmaceutical-grade sucrose are a potential threat to protein stability. Pharm Res  2017,34(12),2910-2921","journal-title":"Pharm Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","volume":"5","author":"Vargason A.M.","year":"2021","unstructured":"Vargason A.M.; Anselmo A.C.; Mitragotri S.; The evolution of commercial drug delivery technologies. Nat Biomed Eng  2021,5(9),951-967","journal-title":"Nat Biomed Eng"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1080\/21655979.2022.2031412","volume":"13","author":"Kumar V.","year":"2022","unstructured":"Kumar V.; Bansal V.; Madhavan A.; Kumar M.; Sindhu R.; Awasthi M.K.; Binod P.; Saran S.; Active pharmaceutical ingredient (API) chemicals: A critical review of current biotechnological approaches. Bioengineered  2022,13(2),4309-4327","journal-title":"Bioengineered"},{"key":"ref=22","unstructured":"Low-in-nanoparticulate-impurities sucrose for biopharmaceutical formulations; Nelli erwin merck, markus greulich merck, tanja henzler merck, marcus nagel coriolis, georg schuster coriolis. Andrea Hawe Coriolis  Available fromL  www.pharmaexcipients.com\/wp-content\/uploads\/2021\/06\/Low-in-nanoparticulate-impurities-sucrose-for-biopharmaceutical-formulations-Merck-Millipore-Sigma.pdf (accessed on: Jan 03, 2024).","journal-title":"Andrea Hawe Coriolis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.xphs.2020.11.011","volume":"110","author":"Grabarek A.","year":"2021","unstructured":"Grabarek A.; Nabhan M.; Turbica I.; Hawe A.; Pallardy M.; Jiskoot W.; Immunological evaluation in vitro of nanoparticulate impurities isolated from pharmaceutical-grade sucrose. J Pharm Sci  2021,110(2),952-958","journal-title":"J Pharm Sci"},{"key":"ref=24","year":"2021","unstructured":"European Patent Application; EP 3 318 281 A1 Coriolis Pharma Research GmbH 82152 Martinsried (DE)  2021","journal-title":"Coriolis Pharma Research GmbH 82152 Martinsried (DE)"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s100470300008","volume":"6","author":"Nagasawa K","year":"2003","unstructured":"Nagasawa K; Yano T; Kitabayashi G; Morimoto H; Yamada Y; Ohata A; Usami M; Horiuchi T; Experimental proof of contamination of blood components by (1\u2192 3)-\u03b2-d-glucan caused by filtration with cellulose filters in the manufacturing process. J Artif Org  2003,6(1),49-54","journal-title":"J Artif Org"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/btpr.1718","volume":"29","author":"Gefroh E.","year":"2013","unstructured":"Gefroh E.; Hewig A.; Vedantham G.; McClure M.; Krivosheyeva A.; Lajmi A.; Lu Y.; Multipronged approach to managing beta\u2010glucan contaminants in the downstream process: Control of raw materials and filtration with charge-modified nylon 6,6 membrane filters. Biotechnol Prog  2013,29(3),672-680","journal-title":"Biotechnol Prog"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/btpr.2359","volume":"32","author":"Vigor K.","year":"2016","unstructured":"Vigor K.; Emerson J.; Scott R.; Cheek J.; Barton C.; Bax H.J.; Josephs D.H.; Karagiannis S.N.; Spicer J.F.; Lentfer H.; Development of downstream processing to minimize beta-glucan impurities in GMP-manufactured therapeutic antibodies. Biotechnol Prog  2016,32(6),1494-1502","journal-title":"Biotechnol Prog"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijbiomac.2016.06.057","volume":"93","author":"Wang M","year":"2016","unstructured":"Wang M; Zhang L; Yang R; Fei C; Wang X; Zhang K; Wang C; Zheng W; Xue F; Improvement of immune responses to influenza vaccine (H5N1) by sulfated yeast beta-glucan. Int J Biol Macromol  2016,93(Pt A),203-207","journal-title":"Int J Biol Macromol"},{"key":"ref=29","volume":"31","author":"Sandle T.","year":"2013","unstructured":"Sandle T.; Pharmaceutical product impurities: Considering beta glucans.  Am Pharm Rev Posted  2013,31","journal-title":"Am Pharm Rev Posted"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1756-8722-2-25","volume":"2","author":"Chan G.C.F.","year":"2009","unstructured":"Chan G.C.F.; Chan W.K.; Sze D.M.Y.; The effects of \u03b2-glucan on human immune and cancer cells. J Hematol Oncol  2009,2(1),25","journal-title":"J Hematol Oncol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00262-016-1875-9","volume":"65","author":"Barton C.","year":"2016","unstructured":"Barton C.; Vigor K.; Scott R.; Jones P.; Lentfer H.; Bax H.J.; Josephs D.H.; Karagiannis S.N.; Spicer J.F.; Beta-glucan contamination of pharmaceutical products: How much should we accept? Cancer Immunol Immunother  2016,65(11),1289-1301","journal-title":"Cancer Immunol Immunother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e04345-22","DOI":"10.1128\/spectrum.04345-22","volume":"11","author":"Qi Y.","year":"2023","unstructured":"Qi Y.; Bruni G.O.; Klasson K.T.; Microbiome analysis of sugarcane juices and biofilms from Louisiana raw sugar factories. Microbiol Spectr  2023,11(3),e04345-22","journal-title":"Microbiol Spectr"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.2174\/138161206778743529","volume":"12","author":"Muta T.","year":"2006","unstructured":"Muta T.; Molecular basis for invertebrate innate immune recognition of (1-->3)-\u03b2-D-glucan as a pathogen-associated molecular pattern. Curr Pharm Des  2006,12(32),4155-4161","journal-title":"Curr Pharm Des"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-90-481-9078-2_1","volume":"53","author":"Wang X.","year":"2010","unstructured":"Wang X.; Quinn P.J.; Endotoxins: Lipopolysaccharides of Gram-negative bacteria. Subcell Biochem  2010,53,3-25","journal-title":"Subcell Biochem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/biomedicines9050536","volume":"9","author":"Tamura H.","year":"2021","unstructured":"Tamura H.; Reich J.; Nagaoka I.; Outstanding contributions of LAL technology to pharmaceutical and medical science: Review of methods, progress, challenges, and future perspectives in early detection and management of bacterial infections and invasive fungal diseases. Biomedicines  2021,9(5),536","journal-title":"Biomedicines"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajps.2017.11.003","volume":"13","author":"Jin Y.","year":"2018","unstructured":"Jin Y.; Jia J.; Li C.; Xue J.; Sun J.; Wang K.; Gan Y.; Xu J.; Shi Y.; Liang X.; LAL test and RPT for endotoxin detection of CPT-11\/DSPE-mPEG nanoformulation: What if traditional methods are not applicable? Asian J Pharm Sci  2018,13(3),289-296","journal-title":"Asian J Pharm Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/microorganisms8111728","volume":"8","author":"Bech \u00d8rving R.","year":"2020","unstructured":"Bech \u00d8rving R.; Carpenter B.; Roth S.; Reich J.; Kallipolitis B.H.; Sonne-Hansen J.; Bacterial endotoxin testing\u2014fast endotoxin masking kinetics in the presence of lauryldimethylamine oxide. Microorganisms  2020,8(11),1728","journal-title":"Microorganisms"},{"key":"ref=38","first-page":"381","volume":"7","author":"Bukhari M.M.","year":"2015","unstructured":"Bukhari M.M.; Salem E.K.; Osman A.; Hegazi S.E.; Investigations of the influence of dextran on sugar cane quality and sugar cane processing in Kenana sugar factory. J Chem Pharm Res  2015,7(4),381-392","journal-title":"J Chem Pharm Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/polysaccharides2030033","volume":"2","author":"D\u00edaz-Montes E.","year":"2021","unstructured":"D\u00edaz-Montes E.; Dextran: Sources, structures, and properties. Polysaccharides  2021,2(3),554-565","journal-title":"Polysaccharides"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/bit.26859","volume":"116","author":"Fernandez-Cerezo L.","year":"2019","unstructured":"Fernandez-Cerezo L.; Rayat A.C.M.E.; Chatel A.; Pollard J.M.; Lye G.J.; Hoare M.; An ultra scale-down method to investigate monoclonal antibody processing during tangential flow filtration using ultrafiltration membranes. Biotechnol Bioeng  2019,116(3),581-590","journal-title":"Biotechnol Bioeng"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-9145-7_18","volume":"1953","author":"Nordin J.Z.","year":"2019","unstructured":"Nordin J.Z.; Bostancioglu R.B.; Corso G.; EL Andaloussi S.; Tangential flow filtration with or without subsequent bind-elute size exclusion chromatography for purification of extracellular vesicles. Methods Mol Biol  2019,1953,287-299","journal-title":"Methods Mol Biol"},{"key":"ref=42","author":"Weinbuch D.","year":"2016","unstructured":"Weinbuch D.; Hawe A.; Jiskoot W.; Highly purified sugars and sugar compositions. European Patent, EP3318281B1  2016","journal-title":"European Patent, EP3318281B1"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018290111240119115306","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226520\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018290111240119115306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T04:48:50Z","timestamp":1752122930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226520\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115672018290111240119115306","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}